Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Hepatitis

  Free Subscription


Articles published in Proc Natl Acad Sci U S A

Retrieve available abstracts of 38 articles:
HTML format



Single Articles


    July 2021
  1. DENG L, Hernandez N, Zhong L, Holcomb DD, et al
    A conserved epitope III on hepatitis C virus E2 protein has alternate conformations facilitating cell binding or virus neutralization.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    June 2021
  2. HIRANO J, Yoshio S, Sakai Y, Songling L, et al
    Hepatitis C virus modulates signal peptide peptidase to alter host protein processing.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    April 2021
  3. LECOQ L, Wang S, Dujardin M, Zimmermann P, et al
    A pocket-factor-triggered conformational switch in the hepatitis B virus capsid.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  4. LOPEZ ANGEL CJ, Pham EA, Du H, Vallania F, et al
    Signatures of immune dysfunction in HIV and HCV infection share features with chronic inflammation in aging and persist after viral reduction or elimination.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    March 2021
  5. RASCHE A, Lehmann F, Goldmann N, Nagel M, et al
    A hepatitis B virus causes chronic infections in equids worldwide.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  6. KIM GW, Siddiqui A
    N6-methyladenosine modification of HCV RNA genome regulates cap-independent IRES-mediated translation via YTHDC2 recognition.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    January 2021
  7. KIM GW, Siddiqui A
    Hepatitis B virus X protein recruits methyltransferases to affect cotranscriptional N6-methyladenosine modification of viral/host RNAs.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  8. GUEST JD, Wang R, Elkholy KH, Chagas A, et al
    Design of a native-like secreted form of the hepatitis C virus E1E2 heterodimer.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  9. BERGNER LM, Orton RJ, Broos A, Tello C, et al
    Diversification of mammalian deltaviruses by host shifting.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    September 2020
  10. METRAS R, Edmunds WJ, Youssouffi C, Dommergues L, et al
    Estimation of Rift Valley fever virus spillover to humans during the Mayotte 2018-2019 epidemic.
    Proc Natl Acad Sci U S A. 2020;117:24567-24574.
    PubMed     Abstract available


    July 2020
  11. PARASKEVOPOULOU S, Pirzer F, Goldmann N, Schmid J, et al
    Mammalian deltavirus without hepadnavirus coinfection in the neotropical rodent Proechimys semispinosus.
    Proc Natl Acad Sci U S A. 2020;117:17977-17983.
    PubMed     Abstract available


    May 2020
  12. VERMA M, Chu JN, Salama JAF, Faiz MT, et al
    Development of a long-acting direct-acting antiviral system for hepatitis C virus treatment in swine.
    Proc Natl Acad Sci U S A. 2020 May 18. pii: 2004746117.
    PubMed     Abstract available


    March 2020
  13. HO TC, Wang EY, Yeh KH, Jeng YM, et al
    Complement C1q mediates the expansion of periportal hepatic progenitor cells in senescence-associated inflammatory liver.
    Proc Natl Acad Sci U S A. 2020;117:6717-6725.
    PubMed     Abstract available


    January 2020
  14. MICHAILIDIS E, Vercauteren K, Mancio-Silva L, Andrus L, et al
    Expansion, in vivo-ex vivo cycling, and genetic manipulation of primary human hepatocytes.
    Proc Natl Acad Sci U S A. 2020;117:1678-1688.
    PubMed     Abstract available


  15. TODT D, Friesland M, Moeller N, Praditya D, et al
    Robust hepatitis E virus infection and transcriptional response in human hepatocytes.
    Proc Natl Acad Sci U S A. 2020 Jan 2. pii: 1912307117.
    PubMed     Abstract available


    August 2019
  16. RASCHE A, Lehmann F, Konig A, Goldmann N, et al
    Highly diversified shrew hepatitis B viruses corroborate ancient origins and divergent infection patterns of mammalian hepadnaviruses.
    Proc Natl Acad Sci U S A. 2019 Aug 1. pii: 1908072116.
    PubMed     Abstract available


    April 2019
  17. PRENTOE J, Velazquez-Moctezuma R, Augestad EH, Galli A, et al
    Hypervariable region 1 and N-linked glycans of hepatitis C regulate virion neutralization by modulating envelope conformations.
    Proc Natl Acad Sci U S A. 2019 Apr 30. pii: 1822002116.
    PubMed     Abstract available


  18. IWAMOTO M, Saso W, Sugiyama R, Ishii K, et al
    Epidermal growth factor receptor is a host-entry cofactor triggering hepatitis B virus internalization.
    Proc Natl Acad Sci U S A. 2019 Apr 5. pii: 1811064116.
    PubMed     Abstract available


    March 2019
  19. QU C, Wang Y, Wang P, Chen K, et al
    Detection of early-stage hepatocellular carcinoma in asymptomatic HBsAg-seropositive individuals by liquid biopsy.
    Proc Natl Acad Sci U S A. 2019;116:6308-6312.
    PubMed     Abstract available


    January 2019
  20. WILSON DJ
    The harmonic mean p-value for combining dependent tests.
    Proc Natl Acad Sci U S A. 2019;116:1195-1200.
    PubMed     Abstract available


    December 2018
  21. FURUSE Y
    Analysis of research intensity on infectious disease by disease burden reveals which infectious diseases are neglected by researchers.
    Proc Natl Acad Sci U S A. 2018 Dec 31. pii: 1814484116.
    PubMed     Abstract available


    November 2018
  22. CHEN Z, Diaz G, Pollicino T, Zhao H, et al
    Role of humoral immunity against hepatitis B virus core antigen in the pathogenesis of acute liver failure.
    Proc Natl Acad Sci U S A. 2018 Nov 12. pii: 1809028115.
    PubMed     Abstract available


    August 2018
  23. IMAM H, Khan M, Gokhale NS, McIntyre ABR, et al
    N6-methyladenosine modification of hepatitis B virus RNA differentially regulates the viral life cycle.
    Proc Natl Acad Sci U S A. 2018 Aug 13. pii: 1808319115.
    PubMed     Abstract available


    July 2018
  24. LO IACONO G, Cunningham AA, Bett B, Grace D, et al
    Environmental limits of Rift Valley fever revealed using ecoepidemiological mechanistic models.
    Proc Natl Acad Sci U S A. 2018;115:E7448-E7456.
    PubMed     Abstract available


  25. KINCAID RP, Lam VL, Chirayil RP, Randall G, et al
    RNA triphosphatase DUSP11 enables exonuclease XRN-mediated restriction of hepatitis C virus.
    Proc Natl Acad Sci U S A. 2018 Jul 23. pii: 1802326115.
    PubMed     Abstract available


  26. KE R, Li H, Wang S, Ding W, et al
    Superinfection and cure of infected cells as mechanisms for hepatitis C virus adaptation and persistence.
    Proc Natl Acad Sci U S A. 2018 Jul 9. pii: 1805267115.
    PubMed     Abstract available


    June 2018
  27. ALEMAN F, Tzarum N, Kong L, Nagy K, et al
    Immunogenetic and structural analysis of a class of HCV broadly neutralizing antibodies and their precursors.
    Proc Natl Acad Sci U S A. 2018 Jun 28. pii: 1802378115.
    PubMed     Abstract available


    April 2018
  28. YIN X, Ying D, Lhomme S, Tang Z, et al
    Origin, antigenicity, and function of a secreted form of ORF2 in hepatitis E virus infection.
    Proc Natl Acad Sci U S A. 2018 Apr 18. pii: 1721345115.
    PubMed     Abstract available


    December 2017
  29. MANKOWSKI MC, Kinchen VJ, Wasilewski LN, Flyak AI, et al
    Synergistic anti-HCV broadly neutralizing human monoclonal antibodies with independent mechanisms.
    Proc Natl Acad Sci U S A. 2017 Dec 18. pii: 1718441115.
    PubMed     Abstract available



  30. Correction for Giang et al., Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus.
    Proc Natl Acad Sci U S A. 2017 Dec 11. pii: 1720228115.
    PubMed    


    November 2017
  31. HIRANO J, Okamoto T, Sugiyama Y, Suzuki T, et al
    Characterization of SPP inhibitors suppressing propagation of HCV and protozoa.
    Proc Natl Acad Sci U S A. 2017 Nov 29. pii: 1712484114.
    PubMed     Abstract available


    June 2017
  32. CAO D, Cao QM, Subramaniam S, Yugo DM, et al
    Pig model mimicking chronic hepatitis E virus infection in immunocompromised patients to assess immune correlates during chronicity.
    Proc Natl Acad Sci U S A. 2017 Jun 19. pii: 201705446.
    PubMed     Abstract available


  33. KIRKEGAARD K
    Unconventional secretion of hepatitis A virus.
    Proc Natl Acad Sci U S A. 2017 Jun 12. pii: 201707142.
    PubMed    



  34. Correction for Ding et al., Hepatitis E virus ORF3 is a functional ion channel required for release of infectious particles.
    Proc Natl Acad Sci U S A. 2017 Jun 5. pii: 201708260.
    PubMed    


    May 2017
  35. PADMANABHAN P, Dixit NM
    Inhibitors of hepatitis C virus entry may be potent ingredients of optimal drug combinations.
    Proc Natl Acad Sci U S A. 2017 May 16. pii: 201704531.
    PubMed    


  36. OHASHI H, Koizumi Y, Fukano K, Wakita T, et al
    Reply to Padmanabhan and Dixit: Hepatitis C virus entry inhibitors for optimally boosting direct-acting antiviral-based treatments.
    Proc Natl Acad Sci U S A. 2017 May 16. pii: 201705234.
    PubMed    


  37. MCKNIGHT KL, Xie L, Gonzalez-Lopez O, Rivera-Serrano EE, et al
    Protein composition of the hepatitis A virus quasi-envelope.
    Proc Natl Acad Sci U S A. 2017 May 10. pii: 201619519.
    PubMed     Abstract available


    April 2017
  38. HANSEN MD, Johnsen IB, Stiberg KA, Sherstova T, et al
    Hepatitis C virus triggers Golgi fragmentation and autophagy through the immunity-related GTPase M.
    Proc Natl Acad Sci U S A. 2017 Apr 7. pii: 201616683.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: